College of Graduate Studies, Department of Microbiology and Immunology, Midwestern University, Glendale, Arizona.
Curr Protoc Mol Biol. 2020 Mar;130(1):e118. doi: 10.1002/cpmb.118.
This article describes two methods for amplifying prions present in experimental and clinical samples: the protein misfolding cyclic amplification (PMCA) assay and the real-time quaking-induced conversion (RT-QuIC) assay. Protocols for preparation of amplification substrate and analysis of results are included in addition to those for the individual assays. For each assay, control and suspect samples are mixed with appropriate amplification substrate, which is whole brains from mice in the case of PMCA and recombinant prion protein produced in bacteria for RT-QuIC, followed by cyclic amplification over a number of cycles of sonication (PMCA) or shaking (RT-QuIC) at a consistent incubation temperature. The resultant amplification products are then assessed either by western blotting (PMCA) or based on fluorescent emissions (RT-QuIC). The equipment and expertise necessary for successfully performing either assay vary and will be important factors for individual laboratories to consider when identifying which assay is more appropriate for their experimental design. © 2020 by John Wiley & Sons, Inc. Basic Protocol 1: Prion amplification via protein misfolding cyclic amplification Support Protocol 1: Collection of whole brains from mice and preparation of normal brain homogenate Basic Protocol 2: Prion amplification via real-time quaking-induced conversion Support Protocol 2: Preparation of recombinant truncated white-tailed-deer prion protein.
蛋白质错误折叠循环扩增(PMCA)检测和实时震动诱导转换(RT-QuIC)检测。除了个别检测方法外,还包括扩增底物的制备方案和结果分析方案。对于每种检测方法,将对照和可疑样本与适当的扩增底物混合,对于 PMCA 来说是来自小鼠的整个大脑,对于 RT-QuIC 来说是在细菌中产生的重组朊病毒蛋白,然后在一致的孵育温度下通过多次超声(PMCA)或摇动(RT-QuIC)进行循环扩增。然后通过 Western blot(PMCA)或荧光发射(RT-QuIC)评估所得扩增产物。成功进行这两种检测的设备和专业知识各不相同,这将是各个实验室在确定哪种检测方法更适合其实验设计时需要考虑的重要因素。 © 2020 年由 John Wiley & Sons, Inc. 基本方案 1:通过蛋白质错误折叠循环扩增进行朊病毒扩增 支持方案 1:从小鼠中收集全脑并制备正常脑匀浆 基本方案 2:通过实时震动诱导转换进行朊病毒扩增 支持方案 2:制备重组截短的白尾鹿朊病毒蛋白。